Researchers Discover New Antibiotic for Drug-resistant Bacteria with AI
McMaster University and the Massachusetts Institute of Technology researchers using artificial intelligence (AI) have discovered a new type of antibiotic
Read moreMcMaster University and the Massachusetts Institute of Technology researchers using artificial intelligence (AI) have discovered a new type of antibiotic
Read moreThe GERBU Adjuvant MTM is developed specifically for monoclonal antibody production and offers a high yield of IgG and fused
Read moreEisai Co., Ltd. revealed that it has partnered with Bliss Biopharmaceutical (Hangzhou) Co., Ltd. to develop BB-1701, an antibody-drug conjugate
Read moreBiosynth provides an exceptional range of chemicals, peptides and biochemicals, offering scientists and researchers worldwide unparalleled convenience, choice, and dependability.
Read morePlasma protein binding is a phenomenon where drugs bind to proteins in the blood, thereby reducing the concentration of free,
Read moreAt the Edge of Innovation – Biosynth At the Edge of Innovation – Biosynth, is where Chemistry meets Biology, Products
Read moreCompugen will present new research at AACR 2023 that allows for the accurate detection and study of novel target PVRIG.
Read moreWith the 3-D Life Slow Gelling hydrogel kits, the set-up of 3D cell culture is easy. Growing cells in a
Read moreMachine learning tissue classifiers are one of the most powerful and promising AI-based clinical research solutions for all types of
Read moreChicago Headquartered Tempus, pioneering AI-enabled precision medicine, has entered a third strategic collaboration with pharma giant Pfizer, aiming to gather
Read more